Oculac (Povidone K25)

Oculac is used as an excipient in ophthalmic formulations to improve product performance.

• Viscosity enhancement: increases the thickness of eye drops for better retention on the ocular surface.
• Stabilization: protects active ingredients from degradation and precipitation.
• Comfort improvement: reduces irritation by providing a smoother ocular feel.
• Compatibility: facilitates mixing with a range of active pharmaceutical ingredients in eye solutions.
• Shelf‑life extension: helps maintain product potency over time.

• Povidone K25 is a high‑molecular‑weight polymer that binds water molecules, creating a viscous matrix that slows drainage of the formulation from the eye. This matrix also acts as a protective shield around active ingredients, reducing oxidation and aggregation, thereby enhancing the stability and bioavailability of ophthalmic preparations.

Povidone K25 may cause ocular reactions in some patients.

Common Side Effects

• Burning sensation: mild transient feeling upon instillation.
• Stinging: brief irritation that usually resolves quickly.
• Redness: temporary conjunctival hyperemia.
• Blurred vision: short‑term visual disturbance after application.
• Tearing: increased lacrimation that subsides.
• Itching: mild pruritus of the eyelid margin.

Serious or Rare Side Effects

• Severe allergic reaction: swelling, rash, or hives around the eye.
• Anaphylaxis: rare systemic hypersensitivity requiring immediate medical attention.
• Corneal ulceration: persistent inflammation leading to ulcer formation.
• Persistent inflammation: prolonged conjunctivitis or keratitis.

When using Oculac, consider the following precautions.

• Allergy assessment: avoid if known hypersensitivity to povidone or related compounds.
• Contact lens use: remove lenses before instillation and wait before reinserting.
• Monitoring: observe for signs of irritation or allergic response after first use.
• Contamination prevention: do not use if the container is opened or the solution appears cloudy.
• Pediatric use: consult a specialist before administering to children.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Povidone K25 may interact with other ophthalmic agents.

Major Interactions (Avoid)

• Incompatible preservatives: mixing with certain benzalkonium chloride formulations can cause precipitation.
• Reactive polymers: combining with other high‑viscosity polymers may alter solution stability.

Moderate Interactions (Monitor Closely)

• Antibiotic efficacy: may affect the penetration of some topical antibiotics.
• Contact lens solutions: can interfere with lens cleaning agents.
• pH‑sensitive drugs: may modify the pH balance of combined formulations.